The Global Fund to Fight AIDS, Tuberculosis and Malaria “expects to have an additional $1.6 billion to fund projects in 2012-2014, [the fund’s General Manager Gabriel Jaramillo] said on Wednesday, a turnaround from a funding freeze last year,” Reuters reports (Miles, 5/9). “The new funds are a result of ‘strategic decisions made by the Board, freeing up funds that can be invested in countries where there is the most pressing demand,’ a statement by the fund said,” according to PlusNews (5/10). “The money includes funds from new donors, from traditional donors who are advancing their payments or increasing contributions and from some donors, such as China, that have offered to support projects in their own country to free up cash for more pressing needs elsewhere, Jaramillo said,” Reuters notes (5/9). “This forecast is better than expected, and it comes from the fantastic response we are getting to our transformation,” Jaramillo said, adding, “But we need more to get the job done. Countries that implement our grants are saving more and more people, but demand for services is still enormous,” according to the statement (5/9).
U.S. Ambassador to Nigeria Terence McCulley on Tuesday in Abuja, Nigeria, launched a five-year, $224 million USAID program, titled Strengthening Integrated Delivery of HIV/AIDS Services (SIDHAS), that aims to “increas[e] access to high-quality comprehensive HIV/AIDS and tuberculosis prevention, treatment, care and related services through improved efficiencies in service delivery,” the Daily Trust reports (Odeyemi/Odafor, 5/8).
“While the battle against HIV/AIDS attracts more donor funding globally than all other diseases combined, it has not diverted attention from fighting unrelated afflictions — such as malaria, measles and malnutrition — and may be improving health services overall in targeted countries, according to a study on Rwanda published” Wednesday in the American Journal of Tropical Medicine and Hygiene, an American Society of Tropical Medicine and Hygiene (ASTMH) press release reports. “A six-year investigation of health clinics in Rwanda by researchers at Brandeis University infuses fresh evidence into a long-standing debate about whether the intensive focus on HIV/AIDS, which in 2010 alone killed 1.8 million people, is undermining other health services, particularly in African countries that are at the epicenter of the pandemic,” the press release states (5/2).
The Center for Global Health Policy’s “Science Speaks” blog continued its coverage of the 2nd International Treatment as Prevention Workshop in Vancouver. One post describes a presentation by Zunyou Wu, director of the Chinese Center for Disease Control and Prevention (CDC), who “offered … new information about China’s response to new evidence on treatment as prevention” (Lubinski, 4/25). A second post discusses a presentation by Vladimir Novitsky of the Harvard School of Public Health, who “offered … a snapshot of a four-year treatment as prevention study planned for Botswana (Lubinski, 4/25). “Chewe Luo, a senior adviser for UNICEF, discussed efforts to eliminate vertical HIV transmission from the perspective of treatment as prevention,” according to a third post (Lubinski, 4/26). Finally, Stephen Lawn of the London School of Hygiene and Tropical Medicine “reminded the audience … that antiretroviral therapy (ART) goes a long way to protect HIV-infected individuals from tuberculosis (TB),” a fourth post notes (Lubinski, 4/26).
In this post in her Global Health Blog, Guardian Health Editor Sarah Boseley examines the potential impact of reform within the Global Fund to Fight AIDS, Tuberculosis and Malaria on the organization’s future. She writes, “It’s been only seven weeks since banker Gabriel Jaramillo took over as general manager of the [fund], but it is already clear the worthy organization set up by Kofi Annan to channel money to treat and prevent diseases in poor countries is a leaner, meaner machine.” She continues, “Jaramillo, former chair and chief executive of Sovereign Bank, brings a tougher attitude to the organization.”
South Africa’s recently released “National Strategic Plan on HIV, Sexually Transmitted Infections (STIs) and Tuberculosis (TB) 2012-2016” “marked an important milestone” in the nation’s fight against infectious diseases, a Lancet editorial states. “The plan [.pdf] has several broad goals: to reduce new HIV infections by at least 50 percent; to start at least 80 percent of eligible patients on antiretroviral treatment; to reduce the number of new tuberculosis infections and deaths by 50 percent; to ensure a legal framework that protects and promotes human rights to support implementation of the plan; and to reduce self-reported stigma related to HIV and tuberculosis by at least 50 percent,” the editorial notes.
In this post on the State Department’s “DipNote” blog, U.S. Global AIDS Coordinator Ambassador Eric Goosby provides an update on the Global Fund to Fight AIDS, Tuberculosis and Malaria, stating, “I am buoyed by the reform that is happening at the Fund under the leadership of new General Manager Gabriel Jaramillo.” He adds, “When PEPFAR and the Fund coordinate, our investments against AIDS are expanded both geographically and programmatically. Simply put, a strong PEPFAR requires a strong Global Fund.” Goosby concludes, “I am proud of the U.S. commitment to the Global Fund, in part because it is a commitment to the work of PEPFAR. We have a unique opportunity in a tight fiscal environment to support the Fund at this critical juncture” (4/9).
A new analysis from amfAR (.doc), The Foundation for AIDS Research, “estimates potential human impacts of funding changes [in global health programs] proposed in the President’s fiscal year 2013 budget request when compared to current operating budget levels (fiscal year 2012).” President Obama’s FY 2013 budget request includes a decrease in funding for PEPFAR and an increase in funding for the Global Fund to Fight AIDS, Tuberculosis and Malaria, according to the analysis, which concludes, “Taken together, proposed changes in funding for the Global Fund and PEPFAR could lead to significant reductions in lifesaving AIDS treatment delivery, services to orphans and other vulnerable children, prevention of vertical HIV transmission (from mother-to-child) services, and HIV testing services that could otherwise have been delivered with flat funding for PEPFAR” (April 2012).
The Center for Global Health Policy’s “Science Speaks” blog summarizes an event hosted by USAID in late March to commemorate World Tuberculosis (TB) Day. The blog includes “brief profiles and pictures of some of the survivors featured in the event ‘Voices of TB.'” Andre Gariseb of Namibia, who was cured of TB in 2009, said at the event, “[TB] is a battle for everybody â€¦ As long as we share the same air it becomes everybody’s problem,” according to the blog (Mazzotta, 4/2).
According to a study recently published in a special supplement of the Journal of Infectious Diseases, half of countries receiving grants from the Global Fund to Fight AIDS, Tuberculosis and Malaria provide tuberculosis (TB) services in prisons; “even when TB services were provided to prisoners, they were limited in scope; and “[f]ew of the programs receiving a grant from the Global Fund offered services dedicated to the treatment and prevention of multi-drug resistant TB (MDR-TB),” an aidsmap news story reports. TB is a leading cause of death among incarcerated individuals worldwide, aidsmap notes. The study authors concluded, “There is an urgent need to better understand the financing needs and cost-effective service delivery models for tuberculosis care in prisons,” according to the story (Carter, 3/30).